AdaptHealth Corp. (AHCO) stock forecast and price target
Price $7.66 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($7.66)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.98 | −281.2% | $2.9B |
| Next fiscal year ends December 31, 2027 | $-0.16 | +83.4% | $3.0B |
| Next quarter ends December 31, 2026 | $-0.04 | −113.6% | $720M |
| Quarter after ends March 31, 2027 | $-0.09 | −79.6% | $721M |
Consensus of the analysts covering AdaptHealth, updated daily.
Our model vs. Wall Street
Analysts see 15.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts AdaptHealth’s intrinsic value about 34% below today’s market value, and it scores 1.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the AdaptHealth stock price target?
The average 12-month target from 7 analysts is $8.86, 15.6% above the current price of $7.66 Targets range from $8.00 to $10.00.
Is AdaptHealth a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is AdaptHealth expected to earn?
Analysts expect EPS of $-0.98 for the fiscal year ending December 31, 2026 and $-0.16 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.